HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neutron-activatable holmium-containing mesoporous silica nanoparticles as a potential radionuclide therapeutic agent for ovarian cancer.

AbstractUNLABELLED:
Mesoporous silica nanoparticles (MSNs) were explored as a carrier material for the stable isotope (165)Ho and, after neutron capture, its subsequent therapeutic radionuclide, (166)Ho (half-life, 26.8 h), for use in radionuclide therapy of ovarian cancer metastasis.
METHODS:
(165)Ho-MSNs were prepared using (165)Ho-acetylacetonate and MCM-41 silica particles, and stability was determined after irradiation in a nuclear reactor (reactor power, 1 MW; thermal neutron flux of approximately 5.5 × 10(12) neutrons/cm(2)s). SPECT/CT and tissue biodistribution studies were performed after intraperitoneal administration of (166)Ho-MSNs to SKOV-3 ovarian tumor-bearing mice. Radiotherapeutic efficacy was studied by using PET/CT with (18)F-FDG to determine tumor volume and by monitoring survival.
RESULTS:
The holmium-MSNs were able to withstand long irradiation times in a nuclear reactor and did not release (166)Ho after significant dilution. SPECT/CT images and tissue distribution results revealed that (166)Ho-MSNs accumulated predominantly in tumors (32.8% ± 8.1% injected dose/g after 24 h; 81% ± 7.5% injected dose/g after 1 wk) after intraperitoneal administration. PET/CT images showed reduced (18)F-FDG uptake in tumors, which correlated with a marked increase in survival after treatment with approximately 4 MBq of (166)Ho-MSNs.
CONCLUSION:
The retention of holmium in nanoparticles during irradiation and in vivo after intraperitoneal administration as well as their efficacy in extending survival in tumor-bearing mice underscores their potential as a radiotherapeutic agent for ovarian cancer metastasis.
AuthorsAnthony J Di Pasqua, Hong Yuan, Younjee Chung, Jin-Ki Kim, James E Huckle, Chenxi Li, Matthew Sadgrove, Thanh Huyen Tran, Michael Jay, Xiuling Lu
JournalJournal of nuclear medicine : official publication, Society of Nuclear Medicine (J Nucl Med) Vol. 54 Issue 1 Pg. 111-6 (Jan 2013) ISSN: 1535-5667 [Electronic] United States
PMID23100452 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Hydroxybutyrates
  • MCM-41
  • Organometallic Compounds
  • Pentanones
  • Radioisotopes
  • acetyl acetonate
  • Silicon Dioxide
  • Holmium
Topics
  • Animals
  • Cell Line, Tumor
  • Female
  • Gamma Rays
  • Holmium (chemistry)
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Hydroxybutyrates (chemistry)
  • Mice
  • Nanoparticles (chemistry, therapeutic use)
  • Neutrons
  • Organometallic Compounds (chemistry)
  • Ovarian Neoplasms (pathology, radiotherapy)
  • Pentanones (chemistry)
  • Porosity
  • Radioisotopes (therapeutic use)
  • Silicon Dioxide (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: